Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366469 · ClinicalTrials.gov registry record
Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 10
- Enrollment target
NCT01366469 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 10 participants.
The verdict
NCT01366469 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The primary objective of this pilot study is to identify and quantify inflammatory and genetic markers from bronchoalveolar lavage fluid (BALF) and serum in patients with a history of chronic obstructive pulmonary disease (COPD) undergoing elective coronary revascularization (CABG) to determine the risk of developing post operative respiratory failure. To achieve this objective, this proposal outlines the following specific aims: Aim #1. To identify from BALF and serum, the change in inflammatory and genetic markers in patients with a history of COPD undergoing CABG. BALF and serum samples will be obtained at the time of intubation immediately prior to surgery and again upon skin closure immediately after the surgical procedure. Aim #2. To determine the extent to which inflammatory and/or genetic markers correlate with post-operative pulmonary complications defined as prolonged mechanical ventilation (\> 24 hours), pneumonia, and/or tracheostomy. Aim #3. To inform the development and implementation of a large pivotal trial which may impact clinical decision-making during the initial pre-operative outpatient assessment of COPD patients undergoing CABG.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366469
The ClinicalTrials.gov registry entry for NCT01366469 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01366469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01366469 about?
NCT01366469 is a clinical study titled "Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting". The primary objective of this pilot study is to identify and quantify inflammatory and genetic markers from bronchoalveolar lavage fluid (BALF) and serum in patients with a history of chronic obstructive pulmonary disease (COPD) undergoing elective coronary revascularization (CABG) to determine the ...
What is the current status of trial NCT01366469?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2011-04. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT01366469?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.